Studies leveraging NKG2D-CAR constructs to selectively eliminate senescent cells in aged models highlight its potential to modulate immune responses beyond cancer (105, 106), opening avenues for treating degenerative disorders. The gene discussed is KLRK1; the disease is cancer.